Variant report
Variant | nsv971592 |
---|---|
Chromosome Location | chr8:50873330-50874778 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:50861606..50863840-chr8:50871624..50874600,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572749929 | chr8:50873340-50873341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540241709 | chr8:50873347-50873348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147942502 | chr8:50873349-50873350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs193250750 | chr8:50873360-50873361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532240098 | chr8:50873367-50873368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2860009 | chr8:50873406-50873407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185718198 | chr8:50873410-50873411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562690710 | chr8:50873442-50873443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529866080 | chr8:50873456-50873457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189302401 | chr8:50873482-50873483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141740123 | chr8:50873525-50873526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs180901085 | chr8:50873537-50873538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10441571 | chr8:50873608-50873609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147116303 | chr8:50873647-50873648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571355460 | chr8:50873718-50873719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6988557 | chr8:50873729-50873730 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs573620442 | chr8:50873759-50873760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs67415969 | chr8:50873843-50873844 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs374023650 | chr8:50873849-50873850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569404360 | chr8:50873856-50873857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs67856006 | chr8:50873860-50873861 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs185603773 | chr8:50873895-50873896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs368161717 | chr8:50873932-50873933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188749970 | chr8:50873952-50873953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540971800 | chr8:50873963-50873964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573096991 | chr8:50874052-50874053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558563625 | chr8:50874071-50874072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539867976 | chr8:50874117-50874118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545333010 | chr8:50874125-50874126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10441546 | chr8:50874135-50874136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs544263538 | chr8:50874151-50874152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565367894 | chr8:50874168-50874169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565219723 | chr8:50874172-50874173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181377296 | chr8:50874184-50874185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541669335 | chr8:50874185-50874186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560336486 | chr8:50874188-50874189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544272071 | chr8:50874191-50874192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs318893 | chr8:50874200-50874201 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs552081741 | chr8:50874217-50874218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571273218 | chr8:50874279-50874280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13266609 | chr8:50874280-50874281 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs16914099 | chr8:50874313-50874314 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs551486607 | chr8:50874341-50874342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561444880 | chr8:50874465-50874466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530094062 | chr8:50874475-50874476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114619700 | chr8:50874479-50874480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548491438 | chr8:50874505-50874506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567095131 | chr8:50874514-50874515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs318894 | chr8:50874522-50874523 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs76624640 | chr8:50874540-50874541 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:50855200-50875200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr8:50860400-50875400 | Weak transcription | Fetal Intestine Small | intestine |
3 | chr8:50869800-50875000 | Weak transcription | Fetal Brain Male | brain |
4 | chr8:50870200-50875400 | Weak transcription | Fetal Lung | lung |
5 | chr8:50870400-50875400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr8:50870400-50875600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr8:50871000-50874600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr8:50872800-50875400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr8:50873200-50873400 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr8:50873200-50873400 | Enhancers | Brain Germinal Matrix | brain |
11 | chr8:50873400-50874400 | Weak transcription | Brain Germinal Matrix | brain |
12 | chr8:50874400-50874800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
13 | chr8:50874400-50876200 | Enhancers | Brain Germinal Matrix | brain |
14 | chr8:50874600-50874800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr8:50874600-50875600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |